Draft genome sequence of a multidrug-resistant Streptococcus agalactiae sequence type 1665 strain isolated from

Saki Kanehira1, Yusuke Ota2, Kazunari Sonobe1

  • 1Department of Clinical Laboratory, Institute of Science Tokyo Hospital, Tokyo, Japan.

Insights

A drug-resistant Streptococcus agalactiae strain was identified, showing resistance to multiple antibiotics including beta-lactams. Genomic surveillance is crucial for managing invasive infections caused by such resistant bacteria.

Area of Science:

  • Microbiology
  • Genomics
  • Infectious Diseases

Background:

  • Streptococcus agalactiae (Group B Streptococcus) is a significant pathogen.
  • Increasing antimicrobial resistance in S. agalactiae complicates treatment and infection control.
  • The potential for invasive disease necessitates ongoing surveillance.

Purpose of the Study:

  • To characterize a novel strain of Streptococcus agalactiae with a concerning resistance profile.
  • To identify genetic determinants contributing to antimicrobial resistance in this strain.
  • To emphasize the importance of genomic surveillance for Streptococcus agalactiae.

Main Methods:

  • Isolation and identification of Streptococcus agalactiae.
  • Antimicrobial susceptibility testing (phenotypic characterization).
  • Whole-genome sequencing to identify genetic mutations and resistance mechanisms, including analysis of PBP2X variants.

Main Results:

  • A sequence type 1665 Streptococcus agalactiae strain was isolated.
  • The strain exhibited nonsusceptibility to beta-lactams and resistance to macrolides, tetracyclines, and fluoroquinolones.
  • Previously uncharacterized variants in the penicillin-binding protein 2X (PBP2X) were identified.

Conclusions:

  • The emergence of multidrug-resistant Streptococcus agalactiae, including beta-lactam nonsusceptibility, poses a significant public health threat.
  • Genomic surveillance is essential for early detection of resistant strains and informing clinical treatment strategies.
  • Understanding resistance mechanisms, such as novel PBP2X variants, is critical for effective infection control and guiding antimicrobial therapy.

Related Concept Videos

Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Genomic DNA in Prokaryotes00:46

Genomic DNA in Prokaryotes

The genome of most prokaryotic organisms consists of double-stranded DNA organized into one circular chromosome in a region of cytoplasm called the nucleoid. The chromosome is tightly wound, or supercoiled, for efficient storage. Prokaryotes also contain other circular pieces of DNA called plasmids. These plasmids are smaller than the chromosome and often carry genes that confer adaptive functions, such as antibiotic resistance.
Genomic Diversity in Bacteria
Although bacterial genomes are much...
Evolution of Microbial Genome01:08

Evolution of Microbial Genome

Microbial genome evolution is a highly dynamic process shaped by continual gene gain and loss across species and strains. This genomic flexibility allows microorganisms to adapt rapidly to environmental pressures and interactions with other organisms. Central to understanding this diversity is the distinction between the core and pan genomes.The core genome comprises the genes shared by all sampled strains of a species, representing essential functions needed for fundamental cellular processes.